Last reviewed · How we verify
gp75 DNA vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
gp75 DNA vaccine (gp75 DNA vaccine) — Eli Lilly and Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| gp75 DNA vaccine TARGET | gp75 DNA vaccine | Eli Lilly and Company | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- gp75 DNA vaccine CI watch — RSS
- gp75 DNA vaccine CI watch — Atom
- gp75 DNA vaccine CI watch — JSON
- gp75 DNA vaccine alone — RSS
Cite this brief
Drug Landscape (2026). gp75 DNA vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/gp75-dna-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab